Michael Pichichero
| Michael E. Pichichero | |
|---|---|
| Residence | Brighton, Monroe County, New York[1] |
| Fields | Pediatrics, toxicology |
| Institutions | University of Rochester Medical Center |
| Alma mater | University of Rochester School of Medicine |
| Known for | Thimerosal controversy |
| Notable awards | Breese Award for Outstanding Contribution to Clinical Research, Teaching and Practice, 2005 |
Michael E. Pichichero, MD is a clinical professor in the Department of Pediatrics at the University of Rochester Medical Center.[2] He is the author of a number of scientific studies regarding the safety of thimerosal as a preservative in vaccines.
Biography
Pichichero received his undergraduate degree from Rutgers University, and his medical degree from the University of Rochester.[1]
Scientific career
Pichichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of thimerosal-containing vaccines, as well as that administration thereof does not raise blood mercury levels above the EPA's lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as methylmercury (the kind of mercury found in fish), and that the former has a blood half-life of about 3.7 days whereas the latter has a half-life of 44 days.[3] His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.[4][5]
Pichichero has written a textbook about streptococcal pharyngitis.[6] A board-certified immunologist, he was on the team of scientists at the University of Rochester who invented the Hib vaccine.[7] His more recent research, however, has focused on ear infections and their treatment with antibiotics.[8]
Selected publications
- Pichichero, M. E.; Pichichero, D. M. (1998). "Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: Reliability of examination assessed by skin testing and oral challenge". The Journal of Pediatrics 132 (1): 137–143. doi:10.1016/s0022-3476(98)70499-8. PMID 9470015.
- Pichichero, M. E. (2005). "A Review of Evidence Supporting the American Academy of Pediatrics Recommendation for Prescribing Cephalosporin Antibiotics for Penicillin-Allergic Patients". Pediatrics 115 (4): 1048–1057. doi:10.1542/peds.2004-1276. PMID 15805383.
- Kaur, R.; Adlowitz, D. G.; Casey, J. R.; Zeng, M.; Pichichero, M. E. (2010). "Simultaneous Assay for Four Bacterial Species Including Alloiococcus otitidis Using Multiplex-PCR in Children with Culture Negative Acute Otitis Media". The Pediatric Infectious Disease Journal 29 (8): 741–745. doi:10.1097/INF.0b013e3181d9e639. PMC 3581301. PMID 20335823.
References
- 1 2 "Meet our Doctors". Legacy Pediatrics. Retrieved 31 August 2013.
- ↑ "Michael E. Pichichero". University of Rochester Medical Center. Retrieved 31 August 2013.
- ↑ Barclay, Laurie (3 December 2002). "Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD". Medscape. Retrieved 31 August 2013.
- ↑ Johnson, Carla K. (31 January 2008). "Study: Mercury fades quickly from blood". USA Today. Retrieved 31 August 2013.
- ↑ Reinberg, Steven (23 March 2008). "Mercury in Childhood Vaccines Excreted Quickly". ABC News. Retrieved 5 November 2013.
- ↑ Pichichero, Michael (2007). Clinical Management of Streptococcal Pharyngitis. Professional Communications.
- ↑ "Our Researchers". Rochester General Health System. Retrieved 31 August 2013.
- ↑ Dooren, Jennifer (17 October 2007). "Ear Bacteria Resist Treatment". Wall Street Journal. Retrieved 25 November 2014.
External links
- Mercury in Childhood Vaccines Excreted Quickly
- Mercury in Childhood Vaccines Excreted Quickly
- Babies excrete vaccine-mercury quicker than originally thought
|